Skip to main content
Top
Published in: World Journal of Urology 4/2018

01-04-2018 | Letter to the Editor

Reply to letter to editor regarding: LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer

Authors: Marcel Cabral Cognette, Andreza Vargas da Silva, Roberto Dias Machado, Eliney Ferreira Faria

Published in: World Journal of Urology | Issue 4/2018

Login to get access

Excerpt

Dear Dr. Editors-in-Chief: M. Burchardt and A. de la Taille, …
Literature
1.
go back to reference Vargas A, Machado RD, Filho DI, Paiva CE, Dos Reis RB, Tobias-Machado M et al (2016) LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer. World J Urol 34(12):1621–1628CrossRefPubMed Vargas A, Machado RD, Filho DI, Paiva CE, Dos Reis RB, Tobias-Machado M et al (2016) LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer. World J Urol 34(12):1621–1628CrossRefPubMed
3.
go back to reference Timilshina N, Hussain S, Breunis H, Alibhai SM (2011) Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study. Support Care Cancer 19(11):1815–1821CrossRefPubMed Timilshina N, Hussain S, Breunis H, Alibhai SM (2011) Predictors of hemoglobin decline in non-metastatic prostate cancer patients on androgen deprivation therapy: a matched cohort study. Support Care Cancer 19(11):1815–1821CrossRefPubMed
4.
go back to reference Hara N, Nishiyama T, Takizawa I, Saito T, Kitamura Y, Takahashi K (2010) Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis. Urology. 75(6):1441–1445CrossRefPubMed Hara N, Nishiyama T, Takizawa I, Saito T, Kitamura Y, Takahashi K (2010) Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis. Urology. 75(6):1441–1445CrossRefPubMed
5.
go back to reference Sun M, Choueiri TK, Hamnvik OP, Preston MA, De Velasco G, Jiang W et al (2016) Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy. JAMA Oncol 2(4):500–507CrossRefPubMed Sun M, Choueiri TK, Hamnvik OP, Preston MA, De Velasco G, Jiang W et al (2016) Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy. JAMA Oncol 2(4):500–507CrossRefPubMed
6.
go back to reference Chen DY, See LC, Liu JR, Chuang CK, Pang ST, Hsieh IC et al (2017) Risk of cardiovascular ischemic events after surgical castration and gonadotropin-releasing hormone agonist therapy for prostate cancer: a nationwide cohort study. J Clin Oncol 35(32):3697–3705CrossRefPubMed Chen DY, See LC, Liu JR, Chuang CK, Pang ST, Hsieh IC et al (2017) Risk of cardiovascular ischemic events after surgical castration and gonadotropin-releasing hormone agonist therapy for prostate cancer: a nationwide cohort study. J Clin Oncol 35(32):3697–3705CrossRefPubMed
7.
go back to reference Bayoumi AM, Brown AD, Garber AM (2000) Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. J Natl Cancer Inst 92(21):1731–1739CrossRefPubMed Bayoumi AM, Brown AD, Garber AM (2000) Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. J Natl Cancer Inst 92(21):1731–1739CrossRefPubMed
8.
go back to reference Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C et al (1999) Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep/Technol Assess (Summary). 4:i-x Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C et al (1999) Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep/Technol Assess (Summary). 4:i-x
Metadata
Title
Reply to letter to editor regarding: LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer
Authors
Marcel Cabral Cognette
Andreza Vargas da Silva
Roberto Dias Machado
Eliney Ferreira Faria
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 4/2018
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2226-6

Other articles of this Issue 4/2018

World Journal of Urology 4/2018 Go to the issue